Pulsed Electromagnetic Field Therapy for Neuropathic Pain in Lumbar Disc Herniation

February 16, 2026 updated by: Berna Gunay, MD, Haydarpasa Numune Training and Research Hospital

Effectiveness of Pulsed Electromagnetic Field Therapy on Neuropathic Pain and Disability in Patients With Lumbar Disc Herniation: A Randomized, Double-Blind, Placebo-Controlled Trial

This randomized controlled study evaluated whether adding pulsed electromagnetic field (PEMF) therapy to conventional physical therapy provides additional benefits for neuropathic pain and disability in patients with lumbar disc herniation (LDH).

→ This study randomly assigned patients into groups to compare treatments. It examined whether adding pulsed electromagnetic field (PEMF) therapy to standard physical therapy could give extra improvement in nerve-related pain and daily function in people with a slipped disc in the lower back.

Fifty-two patients with ≥3 months of radicular and neuropathic symptoms were enrolled and randomly assigned to a treatment group (PEMF + conventional therapy) or a control group (sham PEMF + conventional therapy).

→ Fifty-two patients who had leg pain and nerve-related symptoms for at least three months joined the study. They were randomly placed into either a treatment group (which received PEMF plus regular therapy) or a control group (which received a fake PEMF treatment plus regular therapy).

Both groups received transcutaneous electrical nerve stimulation, hot packs, and a lumbar exercise program for 15 sessions.

→ Both groups also received the same standard treatments: electrical nerve stimulation, hot packs, and a lower-back exercise program for 15 sessions.

Clinical outcomes-including Visual Analog Scale (VAS), pressure pain threshold, Modified Schober test, DN4, PainDetect, Oswestry Disability Index (ODI), and SF-36-were assessed at baseline, post-treatment, and one month after treatment.

→ Several health measures were checked before treatment, right after treatment, and again one month later. These included pain level (VAS), how sensitive the area was to pressure, lower-back flexibility, nerve-pain questionnaires (DN4 and PainDetect), disability level (ODI), and overall quality of life (SF-36).

Forty-six patients completed the study. → A total of 46 patients finished the study.

Both groups showed significant improvements in VAS scores, neuropathic pain questionnaires (DN4, PainDetect), ODI, and several SF-36 subscales (physical functioning, role-physical, and pain), with additional improvements in emotional role and social functioning observed only in the PEMF group.

→ Both groups improved in many areas: pain levels, nerve-pain scores, disability, and some parts of quality of life (such as physical functioning, daily roles, and pain). Only the PEMF group showed extra improvement in emotional well-being and social activities.

However, none of the between-group comparisons demonstrated significant differences.

  • However, when the two groups were compared to each other, there were no meaningful differences.

No meaningful changes were found in lumbar flexibility or pressure pain thresholds in either group.

→ Neither group showed important changes in lower-back flexibility or in how much pressure they could tolerate on painful areas.

In conclusion, adding PEMF therapy to conventional physical therapy did not provide additional benefit for neuropathic symptoms, radicular pain, disability, lumbar flexibility, pressure pain threshold, or quality of life in patients with LDH-related neuropathic pain.

→ In summary, adding PEMF therapy to regular physical therapy did not give extra benefits for nerve pain, leg pain, disability, back flexibility, sensitivity to pressure, or quality of life in people with nerve-related pain caused by a slipped disc.

Study Overview

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey (Türkiye)
        • Haydarpasa Numune Training and Research Hospital Physical Rehabilitation and Medicine Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • • Radicular pain and neuropathic symptoms lasting longer than 3 months

    • Presence of lumbar disc herniation on lumbar MRI
    • Age between 18 and 75 years
    • Visual Analog Scale (VAS) ≥ 4
    • DN4 ≥ 4
    • At least one positive test among Straight Leg Raise Test (SLRT) and femoral stretch test
    • Patients without cognitive impairment who are able to follow verbal instructions

Exclusion Criteria:

-• Having undergone an interventional lumbar injection within the last 3 months

  • Receiving physical therapy within the last 3 months
  • Using medical treatment for neuropathic pain within the last 3 months
  • History of lumbar surgery
  • Presence of another neurological disorder that could cause neuropathic symptoms
  • Cauda equina syndrome
  • History of malignancy
  • Uncontrolled cardiopulmonary disease
  • Pregnancy
  • Presence of a pacemaker or electronic implant
  • Presence of diabetic neuropathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pulsed electromagnetic field (PEMF) and physical therapy

The physical therapy protocol was arranged as follows: 20 minutes of hot pack application to the lumbar region, 10 minutes of rest, 20 minutes of conventional transcutaneus electrical nerve stimulation (TENS) applied to the lumbar region and along the radicular pain pathway, followed by another 10 minutes of rest, and finally 30 minutes of magnetic field therapy . One session lasted a total of 90 minutes.

On the first day, patients were thoroughly instructed in a home exercise program that included lumbar isometric strengthening, pelvic tilt exercises, hamstring stretching, and core stabilization exercises. They were asked to perform each exercise twice daily with ten repetitions throughout the physical therapy program.

Patients received one session per day, five days per week, for a total of 15 sessions.

In our study, the device used for PEMA application was the BTL-4000 Smart. The PEMA waves applied to the treatment group were elongated square-wave signals with a frequency of 55.55 Hz and a magnetic flux density of 30 mT. A 60-cm solenoid applicator of the device was used. With this applicator, a 30-minute treatment was delivered to cover the lumbar region.
Sham Comparator: Sham Pulsed electromagnetic field (PEMF) and physical therapy

The physical therapy protocol was arranged as follows: 20 minutes of hot pack application to the lumbar region, 10 minutes of rest, 20 minutes of conventional transcutaneus electrical nerve stimulation (TENS) applied to the lumbar region and along the radicular pain pathway, followed by another 10 minutes of rest, and finally 30 minutes of sham magnetic field therapy . One session lasted a total of 90 minutes.

On the first day, patients were thoroughly instructed in a home exercise program that included lumbar isometric strengthening, pelvic tilt exercises, hamstring stretching, and core stabilization exercises. They were asked to perform each exercise twice daily with ten repetitions throughout the physical therapy program.

Patients received one session per day, five days per week, for a total of 15 sessions.

Sham application with the same device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS
Time Frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.
Visual Analog Scale (VAS): VAS is the most frequently used parameter for measuring pain intensity in low back pain studies. It is a self-reported scale that typically consists of a 10-cm horizontal or vertical line with two verbal descriptors placed at each end to indicate the extremes of pain. Patients are asked to mark the point that best represents their pain. The VAS score is obtained by measuring the distance in centimeters from the starting point to the patient's mark. In our study, VAS was used to assess the pain experienced by patients in the low back and leg regions during the previous week. VAS was evaluated in three different conditions: at rest, during movement, and at night.
Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.
PPT
Time Frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

Pressure Pain Threshold (PPT) Measurements with an Algometer:

An algometer is a pressure-measuring device with a 1-cm rounded tip. The sensation of pressure and pain occurs when polymodal nociceptive nerve endings in superficial and deep tissues are stimulated. Algometers are used in clinical studies to measure the pressure pain threshold.

After the measurement points are identified, the rounded tip of the device is placed perpendicular to the surface of the body being examined. Pressure is increased continuously at a rate of approximately 1 kg per second. Patients are instructed to indicate the moment they first feel any pain or discomfort. As soon as they report this sensation, the pressure is stopped and the pressure pain threshold value is read from the device .

In our study, PPTmeasurements obtained with an algometer were used to evaluate the patients' pain sensitivity. The Jtech Commander Algometer was used as the device.

Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neuropathic pain
Time Frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.
DN4 and PainDetect Questionnaire (PDQ)
Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.
Physical examination tests
Time Frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.
Straight Leg Raise Test (SLRT), femoral stretch test, and the Modified Schober test
Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.
Disability
Time Frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.
Oswestry Disability Index (ODI)
Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.
Quality of life Short Form-36 (SF-36) questionnaire
Time Frame: Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.
The SF-36 questionnaire was developed by Ware as a general assessment tool intended for use in many diseases, evaluating quality of life through physical and mental health parameters.
Patients were evaluated before treatment, at the end of treatment, and at the first month after treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2022

Primary Completion (Actual)

July 15, 2023

Study Completion (Actual)

August 15, 2023

Study Registration Dates

First Submitted

November 23, 2025

First Submitted That Met QC Criteria

November 23, 2025

First Posted (Actual)

December 4, 2025

Study Record Updates

Last Update Posted (Actual)

February 18, 2026

Last Update Submitted That Met QC Criteria

February 16, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The study data are available with the researcher and can be provided to the relevant authorities if required.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Disc Herniation With Radiculopathy

Clinical Trials on Pulsed electromagnetic field (PEMF)

Subscribe